Characteristic | Value (%) |
---|---|
Age (years) (Mean ± SD) | 63.40 ± 8.46 |
Sex | Â |
 Male | 94 (96) |
 Female | 4 (4) |
Histologic differentiation grade | Â |
 Poor | 39 (40) |
 Moderate | 52 (53) |
 Well | 7 (7) |
Tumor location | Â |
 Upper | 36 (37) |
 Middle | 42 (43) |
 Lower | 20 (20) |
Clinical T stage | Â |
 T1 | 11 (11) |
 T2 | 27 (28) |
 T3 | 24 (24) |
 T4 | 36 (37) |
Clinical N stage | Â |
 N1 | 31 (32) |
 N2 | 50 (51) |
 N3 | 17 (17) |
AJCC Stage | Â |
 I | 2 (2) |
 II | 11 (11) |
 III | 36 (37) |
 IV | 49 (50) |
Chemotherapy | Â |
 Yes | 83 (85) |
 No | 15 (15) |
SUVTumor (Mean ± SD) | 13.76 ± 5.65 |
MTV (cm3) | 20.88 (11.32, 31.74) |
TLG (g) | 136.90 (68.02, 258.89) |
SUVLN | 6.10 (3.40, 9.97) |
PLNS number | 3 (2,6) |
SDmax(LN-T)(m−1) | 0.37 (0.20,0.59) |